BIO-FD&C (251120) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, BIO-FD&C (251120) reported revenue of 19.2 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202519.2 billion KRW6.3 billion KRW6.7 billion KRW[source]
202416.1 billion KRW4.9 billion KRW4.5 billion KRW[source]
202315.6 billion KRW5.0 billion KRW5.6 billion KRW[source]
202215.9 billion KRW4.9 billion KRW4.3 billion KRW[source]
202112.0 billion KRW3.1 billion KRW2.9 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202573.4 billion KRW3.7 billion KRW69.8 billion KRW[source]
202467.3 billion KRW4.2 billion KRW63.1 billion KRW[source]
202362.8 billion KRW4.2 billion KRW58.6 billion KRW[source]
202259.0 billion KRW6.1 billion KRW53.0 billion KRW[source]
202123.0 billion KRW7.2 billion KRW15.9 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice